Smith Savannah R, Bido Jennifer, Collins Jamie E, Yang Heidi, Katz Jeffrey N, Losina Elena
1Orthopaedic and Arthritis Center for Outcomes Research (S.R.S., J.E.C., H.Y., J.N.K., and E.L.) and Policy, Innovation eValuation in Orthopedic Treatments (PIVOT) Research Center (J.E.C., J.N.K., and E.L.), Department of Orthopaedic Surgery, and Division of Rheumatology, Immunology, and Allergy (J.N.K.), Brigham and Women's Hospital, Boston, Massachusetts 2Harvard Medical School, Boston, Massachusetts 3Departments of Epidemiology and Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 4Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
J Bone Joint Surg Am. 2017 May 17;99(10):803-808. doi: 10.2106/JBJS.16.01200.
There is growing concern about the use of opioids prior to total knee arthroplasty (TKA), and research has suggested that preoperative opioid use may lead to worse pain outcomes following surgery. We evaluated the pain relief achieved by TKA in patients who had and those who had not used opioids use before the procedure.
We augmented data from a prospective cohort study of TKA outcomes with opioid-use data abstracted from medical records. We collected patient-reported outcomes and demographic data before and 6 months after TKA. We used the Pain Catastrophizing Scale and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) to quantify the pain experiences of patients treated with TKA who had had a baseline score of ≥20 on the WOMAC pain scale (a 0 to 100-point scale, with 100 being the worst score), who provided follow-up data, and who had not had another surgical procedure within the 2 years prior to TKA. We built a propensity score for preoperative opioid use based on the Pain Catastrophizing Scale score, comorbidities, and baseline pain. We used a general linear model, adjusting for the propensity score and baseline pain, to compare the change in the WOMAC pain score 6 months after TKA between persons who had and those who had not used opioids before TKA.
The cohort included 156 patients with a mean age of 65.7 years (standard deviation [SD] = 8.2 years) and a mean body mass index (BMI) of 31.1 kg/m (SD = 6.1 kg/m); 62.2% were female. Preoperatively, 36 patients (23%) had had at least 1 opioid prescription. The mean baseline WOMAC pain score was 43.0 points (SD = 12.8) for the group that had not used opioids before TKA and 46.9 points (SD = 15.7) for those who had used opioids (p = 0.12). The mean preoperative Pain Catastrophizing Scale score was greater among opioid users (15.5 compared with 10.7 points among non-users, p = 0.006). Adjusted analyses showed that the opioid group had a mean 6-month reduction in the WOMAC pain score of 27.0 points (95% confidence interval [CI] = 22.7 to 31.3) compared with 33.6 points (95% CI = 31.4 to 35.9) in the non-opioid group (p = 0.008).
Patients who used opioids prior to TKA obtained less pain relief from the operation. Clinicians should consider limiting pre-TKA opioid prescriptions to optimize the benefits of TKA.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
全膝关节置换术(TKA)术前使用阿片类药物的情况日益受到关注,研究表明术前使用阿片类药物可能导致术后疼痛结局更差。我们评估了TKA对术前使用和未使用阿片类药物患者的疼痛缓解情况。
我们将TKA结局的前瞻性队列研究数据与从医疗记录中提取的阿片类药物使用数据相结合。我们收集了TKA术前和术后6个月患者报告的结局及人口统计学数据。我们使用疼痛灾难化量表和西安大略和麦克马斯特大学骨关节炎指数(WOMAC)对WOMAC疼痛量表(0至100分,100分为最差得分)基线评分≥20分、提供了随访数据且在TKA前2年内未进行过其他手术的TKA治疗患者的疼痛体验进行量化。我们基于疼痛灾难化量表评分、合并症和基线疼痛建立了术前阿片类药物使用的倾向评分。我们使用一般线性模型,对倾向评分和基线疼痛进行调整,以比较TKA术前使用和未使用阿片类药物患者术后6个月WOMAC疼痛评分的变化。
该队列包括156例患者,平均年龄65.7岁(标准差[SD]=8.2岁),平均体重指数(BMI)为31.1kg/m(SD=6.1kg/m);62.2%为女性。术前,36例患者(23%)至少有1次阿片类药物处方。TKA术前未使用阿片类药物组的平均基线WOMAC疼痛评分为43.0分(SD=12.8),使用阿片类药物组为46.9分(SD=15.7)(p=0.12)。阿片类药物使用者术前疼痛灾难化量表的平均评分更高(15.5分,非使用者为10.7分,p=0.006)。调整分析显示,阿片类药物组术后6个月WOMAC疼痛评分平均降低27.0分(95%置信区间[CI]=22.7至31.3),而非阿片类药物组为33.6分(95%CI=31.4至35.9)(p=0.008)。
TKA术前使用阿片类药物的患者手术疼痛缓解较少。临床医生应考虑限制TKA术前阿片类药物处方,以优化TKA的益处。
治疗性III级。有关证据水平的完整描述,请参阅作者指南。